(Q36955125)

17 August 2017

Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer (English)

1 reference

17 August 2017

1 reference

1 reference

Graham A Colditz

10

0 references

Rulla M Tamimi

1

object named as

Rulla M Tamimi

1 reference

17 August 2017

9

Stuart J Schnitt

1 reference

17 August 2017

2

Heather J Baer

1 reference

17 August 2017

3

Jonathan Marotti

1 reference

17 August 2017

11

Laura C Collins

1 reference

17 August 2017

Mark Galan

4

1 reference

17 August 2017

Laurie Galaburda

5

1 reference

17 August 2017

Yineng Fu

6

1 reference

17 August 2017

Anne C Deitz

7

1 reference

17 August 2017

James L Connolly

8

1 reference

17 August 2017

5 August 2008

1 reference

17 August 2017

Breast Cancer Research

1 reference

17 August 2017

10

1 reference

17 August 2017

4

1 reference

17 August 2017

R67

1 reference

https://scigraph.springernature.com/pub.10.1186/bcr2128

17 August 2017

0 references

cites work

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

Epidemiology of basal-like breast cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

Pathological and biological differences between screen-detected and interval ductal carcinoma in situ of the breast

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

Molecular classification and molecular forecasting of breast cancer: ready for clinical application?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

Repeated observation of breast tumor subtypes in independent gene expression data sets

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

Breast carcinoma in situ: risk factors and screening patterns

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

Distinctive gene expression patterns in human mammary epithelial cells and breast cancers

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

Differences in risk factors for breast cancer molecular subtypes in a population-based study

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

Identification of a basal-like subtype of breast ductal carcinoma in situ

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

Expression of luminal and basal cytokeratins in human breast carcinoma

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

Risk factors for in situ breast cancer

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer

27 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FBCR2128

Risk factors for breast cancer according to estrogen and progesterone receptor status

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FBCR2128

Incidence of and treatment for ductal carcinoma in situ of the breast.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FBCR2128

Screening-detected and symptomatic ductal carcinoma in situ: mammographic features with pathologic correlation

21 January 2018

1 reference

12 December 2020

Correlations between the mammographic features of ductal carcinoma In situ (DCIS) and C-erbB-2 oncogene expression

1 reference

12 December 2020

Mammographically-detected ductal in situ carcinoma of the breast analyzed with a new classification. A study of 127 cases: correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity

1 reference

12 December 2020

Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial

1 reference

12 December 2020

Identifiers

DOI

10.1186/BCR2128

1 reference

Dimensions Publication ID

17 August 2017

0 references

1 reference

17 August 2017

PubMed publication ID

18681955

1 reference